What impact does tautomerism have on drug discovery and development?
作者信息
Dhaked Devendra K, Nicklaus Marc C
机构信息
Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, India.
Computer-Aided Drug Design Group, Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD, USA.
出版信息
Expert Opin Drug Discov. 2024 Sep;19(9):1011-1016. doi: 10.1080/17460441.2024.2379873. Epub 2024 Jul 16.
Abstract
摘要
相似文献
1
What impact does tautomerism have on drug discovery and development?互变异构对药物发现与开发有何影响？
Expert Opin Drug Discov. 2024 Sep;19(9):1011-1016. doi: 10.1080/17460441.2024.2379873. Epub 2024 Jul 16.
2
R and nlmixr as a gateway between statistics and pharmacometrics.R和nlmixr作为统计学与药理计量学之间的桥梁。
CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):283-285. doi: 10.1002/psp4.12618.
3
The problem of racemization in drug discovery and tools to predict it.手性药物的外消旋化问题及预测工具。
Expert Opin Drug Discov. 2019 Jun;14(6):527-539. doi: 10.1080/17460441.2019.1588881. Epub 2019 Mar 18.
4
Application and Impact of Human Dose Projection from Discovery to Early Drug Development.从发现到早期药物开发的人体剂量预测的应用和影响。
AAPS PharmSciTech. 2020 Jan 2;21(2):44. doi: 10.1208/s12249-019-1598-2.
5
Impact of preformulation on drug development.制剂前研究对药物研发的影响。
Expert Opin Drug Deliv. 2013 Sep;10(9):1239-57. doi: 10.1517/17425247.2013.783563. Epub 2013 Mar 27.
6
Predictive DMPK: in silico ADME predictions in drug discovery.预测性药物代谢和药物动力学：药物研发中的计算机辅助药物吸收、分布、代谢和排泄预测
Mol Pharm. 2013 Apr 1;10(4):1151-2. doi: 10.1021/mp400102t.
7
Model Informed Drug Development: Collaboration Through A Common Framework.模型引导的药物研发：通过通用框架进行协作
Clin Pharmacol Ther. 2021 Nov;110(5):1165-1167. doi: 10.1002/cpt.2066. Epub 2020 Oct 28.
8
An overview of late-stage functionalization in today's drug discovery.当今药物发现中晚期功能化的概述。
Expert Opin Drug Discov. 2019 Nov;14(11):1137-1149. doi: 10.1080/17460441.2019.1653850. Epub 2019 Aug 14.
9
Model-Informed Drug Development: Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics.模型指导的药物研发：以全面证据思维连接各个环节以推进治疗学发展。
Clin Pharmacol Ther. 2021 Nov;110(5):1147-1154. doi: 10.1002/cpt.2422.
10
Raman spectroscopy in pharmaceutical product design.拉曼光谱在药物产品设计中的应用。
Adv Drug Deliv Rev. 2015 Jul 15;89:3-20. doi: 10.1016/j.addr.2015.04.003. Epub 2015 Apr 11.
本文引用的文献
1
Complexation of Fluorofenidone by Cucurbit[7]uril and β-Cyclodextrin: Keto-Enol Tautomerization to Enhance the Solubility.氟苯尼酮与葫芦脲和β-环糊精的包络作用：酮-烯醇互变异构增强溶解度。
Mol Pharm. 2023 Sep 4;20(9):4517-4527. doi: 10.1021/acs.molpharmaceut.3c00213. Epub 2023 Aug 1.
2
Drug Delivery Strategies for Avobenzone: A Case Study of Photostabilization.阿伏苯宗的药物递送策略：光稳定化案例研究
Pharmaceutics. 2023 Mar 21;15(3):1008. doi: 10.3390/pharmaceutics15031008.
3
Importance of tautomerism in drugs.互变异构在药物中的重要性。
Drug Discov Today. 2023 Apr;28(4):103494. doi: 10.1016/j.drudis.2023.103494. Epub 2023 Jan 18.
4
Toward a Comprehensive Treatment of Tautomerism in Chemoinformatics Including in InChI V2.致力于 Chemoinformatics 中包括 InChI V2 在内的互变异构现象的全面处理。
J Chem Inf Model. 2020 Mar 23;60(3):1253-1275. doi: 10.1021/acs.jcim.9b01080. Epub 2020 Mar 10.
5
Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole.黄樟素肝毒性相关反应性代谢物的鉴定与分析。
Xenobiotica. 2018 Nov;48(11):1164-1172. doi: 10.1080/00498254.2017.1399227. Epub 2017 Nov 22.
6
DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy.DL-3-正丁基苯酞-依达拉奉杂合物作为新型双功能抑制剂，可抑制淀粉样β蛋白聚集并抑制单胺氧化酶，对阿尔茨海默病治疗具有高抗氧化效力。
Bioorg Med Chem Lett. 2017 Feb 15;27(4):718-722. doi: 10.1016/j.bmcl.2017.01.050. Epub 2017 Jan 17.
7
Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine δ-Oxidation and Rearrangement.达卡他韦在体外和非临床物种中的生物转化：通过吡咯烷δ-氧化和重排形成主要代谢物。
Drug Metab Dispos. 2016 Jun;44(6):809-20. doi: 10.1124/dmd.115.068866. Epub 2016 Mar 30.
8
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors.姜黄素骨架的多功能性：强效且平衡的双重β-分泌酶1（BACE-1）和糖原合成酶激酶-3β（GSK-3β）抑制剂的发现
J Med Chem. 2016 Jan 28;59(2):531-44. doi: 10.1021/acs.jmedchem.5b00894. Epub 2016 Jan 7.
9
Metabolism-dependent inhibition of CYP3A4 by lapatinib: evidence for formation of a metabolic intermediate complex with a nitroso/oxime metabolite formed via a nitrone intermediate.拉帕替尼通过代谢依赖性抑制 CYP3A4：形成代谢中间复合物的证据，该复合物是通过亚硝酮中间体形成的亚硝基/肟代谢物。
Drug Metab Dispos. 2013 May;41(5):1012-22. doi: 10.1124/dmd.113.051151. Epub 2013 Feb 12.
10
On the kinetics of tautomerism in drugs: New application of broadband dielectric spectroscopy.关于药物互变异构平衡动力学：宽带介电谱的新应用。
J Chem Phys. 2010 Sep 7;133(9):094507. doi: 10.1063/1.3475688.
Zotero 插件